Seres Therapeutics Inc [NASDAQ: MCRB] traded at a low on N/A, posting a -13.44 loss after which it closed the day’ session at $0.40.
The results of the trading session contributed to over 4463117 shares changing hands. Over the past one week, the price volatility of Seres Therapeutics Inc stands at 20.39% while the volatility over the past one month is 11.21%.
The market cap for MCRB stock reached $69.72 million, with 173.01 million shares outstanding and 127.46 million shares in the current float. Compared to the average trading volume of 1.29M shares, MCRB reached a trading volume of 4463117 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Seres Therapeutics Inc [MCRB]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for MCRB shares is $4.08 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on MCRB stock is a recommendation set at 2.20. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
JP Morgan have made an estimate for Seres Therapeutics Inc shares, keeping their opinion on the stock as Underweight, with their previous recommendation back on October 24, 2024. While these analysts kept the previous recommendation, Oppenheimer raised their target price to Outperform. The new note on the price target was released on June 26, 2023, representing the official price target for Seres Therapeutics Inc stock. Previously, the target price had yet another raise to $7, while JP Morgan analysts kept a Neutral rating on MCRB stock. On July 23, 2021, analysts decreased their price target for MCRB shares from 24 to 7.
The Average True Range (ATR) for Seres Therapeutics Inc is set at 0.08 The Price to Book ratio for the last quarter was 5.02, with the Price to Cash per share for the same quarter was set at 0.18.
How has MCRB stock performed recently?
Seres Therapeutics Inc [MCRB] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -25.39. With this latest performance, MCRB shares dropped by -46.44% in over the last four-week period, additionally sinking by -52.16% over the last 6 months – not to mention a drop of -35.28% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for MCRB stock in for the last two-week period is set at 29.76, with the RSI for the last a single of trading hit 26.79, and the three-weeks RSI is set at 32.44 for Seres Therapeutics Inc [MCRB]. The present Moving Average for the last 50 days of trading for this stock 0.7140, while it was recorded at 0.5393 for the last single week of trading, and 0.8545 for the last 200 days.
Seres Therapeutics Inc [MCRB]: Deeper insight into the fundamentals
Seres Therapeutics Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.94 and a Current Ratio set at 0.94.
Insider trade positions for Seres Therapeutics Inc [MCRB]
There are presently around $36.18%, or 41.60%% of MCRB stock, in the hands of institutional investors. The top three institutional holders of MCRB stocks are: FLAGSHIP PIONEERING INC. with ownership of 23.12 million shares, which is approximately 15.2573%. FMR LLC, holding 22.72 million shares of the stock with an approximate value of $$16.44 million in MCRB stocks shares; and FMR LLC, currently with $$4.55 million in MCRB stock with ownership which is approximately 4.3023%.
